348 related articles for article (PubMed ID: 26452974)
1. Zebrafish models of major depressive disorders.
Fonseka TM; Wen XY; Foster JA; Kennedy SH
J Neurosci Res; 2016 Jan; 94(1):3-14. PubMed ID: 26452974
[TBL] [Abstract][Full Text] [Related]
2. Aquatic blues: modeling depression and antidepressant action in zebrafish.
Nguyen M; Stewart AM; Kalueff AV
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Dec; 55():26-39. PubMed ID: 24657522
[TBL] [Abstract][Full Text] [Related]
3. Developing zebrafish models of autism spectrum disorder (ASD).
Stewart AM; Nguyen M; Wong K; Poudel MK; Kalueff AV
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():27-36. PubMed ID: 24315837
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish models: do we have valid paradigms for depression?
de Abreu MS; Friend AJ; Demin KA; Amstislavskaya TG; Bao W; Kalueff AV
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):16-22. PubMed ID: 30030185
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on experimental models of serotonin syndrome in zebrafish.
Stewart AM; Cachat J; Gaikwad S; Robinson KS; Gebhardt M; Kalueff AV
Neurochem Int; 2013 May; 62(6):893-902. PubMed ID: 23485557
[TBL] [Abstract][Full Text] [Related]
6. Understanding zebrafish cognition.
Meshalkina DA; Kizlyk MN; Kysil EV; Collier AD; Echevarria DJ; Abreu MS; Barcellos LJG; Song C; Kalueff AV
Behav Processes; 2017 Aug; 141(Pt 2):229-241. PubMed ID: 27919782
[TBL] [Abstract][Full Text] [Related]
7. Skin too thin? The developing utility of zebrafish skin (neuro)pharmacology for CNS drug discovery research.
Nguyen M; Poudel MK; Stewart AM; Kalueff AV
Brain Res Bull; 2013 Sep; 98():145-54. PubMed ID: 24007957
[TBL] [Abstract][Full Text] [Related]
8. Modeling withdrawal syndrome in zebrafish.
Cachat J; Canavello P; Elegante M; Bartels B; Hart P; Bergner C; Egan R; Duncan A; Tien D; Chung A; Wong K; Goodspeed J; Tan J; Grimes C; Elkhayat S; Suciu C; Rosenberg M; Chung KM; Kadri F; Roy S; Gaikwad S; Stewart A; Zapolsky I; Gilder T; Mohnot S; Beeson E; Amri H; Zukowska Z; Soignier RD; Kalueff AV
Behav Brain Res; 2010 Apr; 208(2):371-6. PubMed ID: 20006651
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical and Behavioral Responses to Unpredictable Chronic Mild Stress Following Developmental Isolation: The Zebrafish as a Model for Major Depression.
Fulcher N; Tran S; Shams S; Chatterjee D; Gerlai R
Zebrafish; 2017 Feb; 14(1):23-34. PubMed ID: 27454937
[TBL] [Abstract][Full Text] [Related]
10. The developing zebrafish (Danio rerio): a vertebrate model for high-throughput screening of chemical libraries.
Lessman CA
Birth Defects Res C Embryo Today; 2011 Sep; 93(3):268-80. PubMed ID: 21932435
[TBL] [Abstract][Full Text] [Related]
11. Developing 'integrative' zebrafish models of behavioral and metabolic disorders.
Nguyen M; Yang E; Neelkantan N; Mikhaylova A; Arnold R; Poudel MK; Stewart AM; Kalueff AV
Behav Brain Res; 2013 Nov; 256():172-87. PubMed ID: 23948218
[TBL] [Abstract][Full Text] [Related]
12. Towards experimental models of delirium utilizing zebrafish.
Maslov GO; Zabegalov KN; Demin KA; Kolesnikova TO; Kositsyn YM; de Abreu MS; Petersen EV; Kalueff AV
Behav Brain Res; 2023 Sep; 453():114607. PubMed ID: 37524203
[TBL] [Abstract][Full Text] [Related]
13. Zebrafish models to study drug abuse-related phenotypes.
Stewart A; Wong K; Cachat J; Gaikwad S; Kyzar E; Wu N; Hart P; Piet V; Utterback E; Elegante M; Tien D; Kalueff AV
Rev Neurosci; 2011; 22(1):95-105. PubMed ID: 21615264
[TBL] [Abstract][Full Text] [Related]
14. The behavioral effects of acute Δ⁹-tetrahydrocannabinol and heroin (diacetylmorphine) exposure in adult zebrafish.
Stewart AM; Kalueff AV
Brain Res; 2014 Jan; 1543():109-19. PubMed ID: 24216135
[TBL] [Abstract][Full Text] [Related]
15. Perspectives of zebrafish models of epilepsy: what, how and where next?
Stewart AM; Desmond D; Kyzar E; Gaikwad S; Roth A; Riehl R; Collins C; Monnig L; Green J; Kalueff AV
Brain Res Bull; 2012 Feb; 87(2-3):135-43. PubMed ID: 22155548
[TBL] [Abstract][Full Text] [Related]
16. The zebrafish tail immobilization (ZTI) test as a new tool to assess stress-related behavior and a potential screen for drugs affecting despair-like states.
Demin KA; Lakstygal AM; Chernysh MV; Krotova NA; Taranov AS; Ilyin NP; Seredinskaya MV; Tagawa N; Savva AK; Mor MS; Vasyutina ML; Efimova EV; Kolesnikova TO; Gainetdinov RR; Strekalova T; Amstislavskaya TG; de Abreu MS; Kalueff AV
J Neurosci Methods; 2020 May; 337():108637. PubMed ID: 32081675
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models.
Stewart A; Wu N; Cachat J; Hart P; Gaikwad S; Wong K; Utterback E; Gilder T; Kyzar E; Newman A; Carlos D; Chang K; Hook M; Rhymes C; Caffery M; Greenberg M; Zadina J; Kalueff AV
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(6):1421-31. PubMed ID: 21122812
[TBL] [Abstract][Full Text] [Related]
18. The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review.
Fontana BD; Mezzomo NJ; Kalueff AV; Rosemberg DB
Exp Neurol; 2018 Jan; 299(Pt A):157-171. PubMed ID: 28987462
[TBL] [Abstract][Full Text] [Related]
19. Psychopharmacological effects of acute exposure to kynurenic acid (KYNA) in zebrafish.
Robinson KS; Stewart AM; Cachat J; Landsman S; Gebhardt M; Kalueff AV
Pharmacol Biochem Behav; 2013 Jul; 108():54-60. PubMed ID: 23583441
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.
Neelkantan N; Mikhaylova A; Stewart AM; Arnold R; Gjeloshi V; Kondaveeti D; Poudel MK; Kalueff AV
ACS Chem Neurosci; 2013 Aug; 4(8):1137-50. PubMed ID: 23883191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
